pre-miRNA Information
pre-miRNA hsa-mir-635   
Genomic Coordinates chr17: 68424451 - 68424548
Synonyms MIRN635, hsa-mir-635, MIR635
Description Homo sapiens miR-635 stem-loop
Comment None
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-635
Sequence 16| ACUUGGGCACUGAAACAAUGUCC |38
Evidence Experimental
Experiments SAGE
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN30524107 5 COSMIC
COSN492359 18 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1431386008 2 dbSNP
rs1200120170 6 dbSNP
rs1477452388 8 dbSNP
rs765045345 10 dbSNP
rs761495041 14 dbSNP
rs1447802278 18 dbSNP
rs994692593 18 dbSNP
rs776535164 23 dbSNP
Putative Targets

Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
B0Q4NY miR-635 Predictive Biomarker (PRD) Transcriptomic Data . . . .
Gene Information
Gene Symbol MTRNR2L10   
Synonyms HN10
Description MT-RNR2-like 10
Transcript NM_001190708   
Expression
Putative miRNA Targets on MTRNR2L10
3'UTR of MTRNR2L10
(miRNA target sites are highlighted)
>MTRNR2L10|NM_001190708|3'UTR
   1 ACAAATAAGACGAGAAGACCCTATGTATGGAGCTTTAATTTATTAATGCAAATAAAAACTTAAGCCTACAGGCCCTAGCC
  81 TACTATCCCTGCATTAAAATTTTTGGTTGGGGTGACCTCAGAGCATAATTCAACCTCCGAGCAACCTAAACTAAGACTGC
 161 ACTAGCCTAAGCAAGTTAATATATATTGACCCGATAATTTGATCAACGGAGTAAGTTACCCTAGGGATAACAGCGCAATC
 241 CTATTCTAGAGTCCATATCAACAATAGGGTTTACAATCTCGATGTTGGATCAGGACATCCTAATGGTGTCACCGCTATTA
 321 GGGGTTCGTTTGTTCAACAATTAAAGTCCTACGTGATGTGAGTTCAGACCAGAGTAATCCAGGTCGGTTTCTATCTATTT
 401 AACATTTCCCCTAGTATGAAAGGACAAGAGAAATAGGGCCCACTTCATAAAGTGCCCTCGCTCCACAGATGATGCTATCT
 481 CAATCTAACAAATCATCACATACCCTACCCAAGAACAGGGTTTGTTAAG
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' ccuguaacaAAGUCA-CGGGUUCa 5'
                   | || | |||:||| 
Target 5' aactaagacTGCACTAGCCTAAGc 3'
149 - 172 130.00 -8.70
2
miRNA  3' ccuguaacaaagucacGGGUUCa 5'
                          |||||| 
Target 5' atcatcacataccctaCCCAAGa 3'
492 - 514 120.00 -9.20
3
miRNA  3' ccuguaacaAAGUCACGGGUUCa 5'
                   | ||| |||| || 
Target 5' acttaagccTACAG-GCCCTAGc 3'
58 - 79 117.00 -11.50
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1220214422 2 dbSNP
rs1324419942 3 dbSNP
rs1294621693 8 dbSNP
rs753966712 9 dbSNP
rs764344566 11 dbSNP
rs186016507 12 dbSNP
rs748208942 18 dbSNP
rs1033235157 22 dbSNP
rs1329392845 33 dbSNP
rs1461049899 44 dbSNP
rs996035552 64 dbSNP
rs1243595605 65 dbSNP
rs747903287 71 dbSNP
rs1485213804 72 dbSNP
rs781329817 79 dbSNP
rs1268156071 87 dbSNP
rs1309962211 88 dbSNP
rs1481438039 90 dbSNP
rs1174577776 94 dbSNP
rs1428918037 99 dbSNP
rs1008856519 105 dbSNP
rs781144231 109 dbSNP
rs886100826 110 dbSNP
rs1047401446 111 dbSNP
rs1445361295 120 dbSNP
rs527992637 126 dbSNP
rs1370579733 131 dbSNP
rs1294869495 138 dbSNP
rs754936496 139 dbSNP
rs1349591063 151 dbSNP
rs1301668351 154 dbSNP
rs149160326 166 dbSNP
rs755125460 175 dbSNP
rs180767302 181 dbSNP
rs868459787 185 dbSNP
rs10521478 192 dbSNP
rs1315438091 193 dbSNP
rs1215748228 195 dbSNP
rs1266501480 198 dbSNP
rs1417358901 203 dbSNP
rs1197415050 204 dbSNP
rs373436446 207 dbSNP
rs938169664 208 dbSNP
rs1488282732 210 dbSNP
rs1440594144 211 dbSNP
rs928161205 221 dbSNP
rs764257563 231 dbSNP
rs1267121101 234 dbSNP
rs1418236441 235 dbSNP
rs562551311 240 dbSNP
rs1367414015 242 dbSNP
rs775806985 243 dbSNP
rs1411289874 245 dbSNP
rs1277371165 246 dbSNP
rs1371665103 251 dbSNP
rs75194172 275 dbSNP
rs111384380 276 dbSNP
rs77988349 277 dbSNP
rs1046623551 278 dbSNP
rs1239362010 281 dbSNP
rs1314552720 285 dbSNP
rs1362302487 292 dbSNP
rs574967656 313 dbSNP
rs1302767220 314 dbSNP
rs76243789 321 dbSNP
rs77862174 322 dbSNP
rs1483400139 323 dbSNP
rs945638069 328 dbSNP
rs1231440936 333 dbSNP
rs76449964 339 dbSNP
rs1480410713 343 dbSNP
rs1219370148 345 dbSNP
rs1366446719 346 dbSNP
rs1386840645 351 dbSNP
rs892342792 353 dbSNP
rs75459765 358 dbSNP
rs1281030647 369 dbSNP
rs76365251 371 dbSNP
rs768048981 372 dbSNP
rs913852788 379 dbSNP
rs5960403 385 dbSNP
rs773967357 386 dbSNP
rs989513921 394 dbSNP
rs373514350 397 dbSNP
rs191438385 399 dbSNP
rs1244460793 400 dbSNP
rs1314901645 403 dbSNP
rs921343219 404 dbSNP
rs1216442530 414 dbSNP
rs1270964077 415 dbSNP
rs1427436149 423 dbSNP
rs750817191 440 dbSNP
rs975517615 455 dbSNP
rs762456736 457 dbSNP
rs5960402 459 dbSNP
rs917554411 460 dbSNP
rs1182938700 482 dbSNP
rs1248623312 484 dbSNP
rs1476334647 491 dbSNP
rs1165720770 494 dbSNP
rs757722034 499 dbSNP
rs111749202 506 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control ...

- Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ccuguaacaaagucacGGGUUCa 5'
                          |||||| 
Target 5' ------------ccuaCCCAAGa 3'
1 - 11
Article - Hafner M; Landthaler M; Burger L; Khorshid et al.
- Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions hESCs (WA-09)
Disease 100463488.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine ...

- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ccuguaacaaagucacGGGUUCa 5'
                          |||||| 
Target 5' -----------cccuaCCCAAGa 3'
1 - 12
Article - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al.
- Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
CLIP-seq Support 1 for dataset GSM545215
Method / RBP PAR-CLIP / AGO4
Cell line / Condition HEK293 / Control
Location of target site ENST00000545075.1 | 3UTR | CCUACCCAAGAACAGGGUUUGUUAA
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset SRR359787
Method / RBP PAR-CLIP / AGO2
Cell line / Condition hESCs (WA-09) / 4-thiouridine, RNase T1
Location of target site ENST00000545075.1 | 3UTR | CCCUACCCAAGAACAGGGUUUGUUAAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 22012620 / SRX103431
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
48 hsa-miR-635 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT055249 CNNM2 cyclin and CBS domain divalent metal cation transport mediator 2 2 2
MIRT150167 MIDN midnolin 2 2
MIRT198486 USP14 ubiquitin specific peptidase 14 2 6
MIRT446204 GTPBP4 GTP binding protein 4 2 2
MIRT453083 SUMF2 sulfatase modifying factor 2 2 6
MIRT462505 MTFMT mitochondrial methionyl-tRNA formyltransferase 2 8
MIRT474413 KLHL28 kelch like family member 28 2 8
MIRT479376 CELF1 CUGBP Elav-like family member 1 2 4
MIRT498090 SEMA7A semaphorin 7A (John Milton Hagen blood group) 2 2
MIRT525565 MTRNR2L7 MT-RNR2-like 7 2 6
MIRT525613 MTRNR2L3 MT-RNR2-like 3 2 4
MIRT531868 POF1B premature ovarian failure, 1B 2 2
MIRT535789 MTRNR2L11 MT-RNR2-like 11 2 6
MIRT535807 MTRNR2L10 MT-RNR2-like 10 2 4
MIRT539940 IFNAR2 interferon alpha and beta receptor subunit 2 2 2
MIRT563194 C15orf38-AP3S2 C15orf38-AP3S2 readthrough 2 2
MIRT563803 AP3S2 adaptor related protein complex 3 sigma 2 subunit 2 2
MIRT576360 Pxdn peroxidasin 2 2
MIRT615575 NCS1 neuronal calcium sensor 1 2 2
MIRT620858 SERPING1 serpin family G member 1 2 2
MIRT623189 NAA15 N(alpha)-acetyltransferase 15, NatA auxiliary subunit 2 2
MIRT625116 SLC1A5 solute carrier family 1 member 5 2 2
MIRT625128 NUP93 nucleoporin 93 2 2
MIRT625904 LINC00632 long intergenic non-protein coding RNA 632 2 2
MIRT626820 PRR11 proline rich 11 2 2
MIRT628142 HM13 histocompatibility minor 13 2 2
MIRT633789 ZNF490 zinc finger protein 490 2 2
MIRT634385 RAP2B RAP2B, member of RAS oncogene family 2 2
MIRT636563 EPB41 erythrocyte membrane protein band 4.1 2 2
MIRT643446 LAX1 lymphocyte transmembrane adaptor 1 2 2
MIRT646006 HTRA1 HtrA serine peptidase 1 2 2
MIRT652141 TRPM7 transient receptor potential cation channel subfamily M member 7 2 2
MIRT652672 TIMELESS timeless circadian clock 2 2
MIRT658341 FAM83D family with sequence similarity 83 member D 2 2
MIRT658890 DRAXIN dorsal inhibitory axon guidance protein 2 2
MIRT659518 CHST3 carbohydrate sulfotransferase 3 2 2
MIRT668590 ELAVL3 ELAV like RNA binding protein 3 2 2
MIRT670258 ZKSCAN3 zinc finger with KRAB and SCAN domains 3 2 2
MIRT686721 TBC1D13 TBC1 domain family member 13 2 2
MIRT701899 MNT MAX network transcriptional repressor 2 2
MIRT702764 IGF1R insulin like growth factor 1 receptor 2 2
MIRT705290 B4GALT1 beta-1,4-galactosyltransferase 1 2 2
MIRT710836 BASP1 brain abundant membrane attached signal protein 1 2 2
MIRT711732 NUPL2 nucleoporin like 2 2 2
MIRT717619 SLC30A10 solute carrier family 30 member 10 2 2
MIRT719453 APBA1 amyloid beta precursor protein binding family A member 1 2 2
MIRT720819 CIAO1 cytosolic iron-sulfur assembly component 1 2 2
MIRT723454 CUL4A cullin 4A 2 2
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-635 Doxorubicin 31703 NSC123127 approved sensitive High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-635 Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-635 Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM36)
hsa-miR-635 Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-635 Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM47)
hsa-miR-635 Paclitaxel 36314 NSC125973 approved resistant cell line (PC3PR200)
hsa-miR-635 Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-635 Docetaxel+Cisplatin+5-Fluorouracil sensitive tissue (hypopharyngeal squamous cell carcinoma)

Error report submission